Vimarsana
Biggest News Aggregation in the World

Page 13 - Aallergic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aallergic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aallergic Today - Breaking & Trending Today

Altamira Therapeutics Reaches Midpoint for Enrollment in Clinical Trial with Bentrio in Seasonal Allergic Rhinitis in Australia - Vimarsana News

Altamira Therapeutics Reaches Midpoint for Enrollment in Clinical Trial with Bentrio in Seasonal Allergic Rhinitis in Australia

Swift progress of study enrollment - midpoint of 50 patients reachedInterim analysis confirmed target enrollment of 100 patientsCompletion of enrollment expected by early January 2023HAMILTON, BERMUDA

With 5.4% CAGR, Allergic Conjunctivitis Market Size worth - Vimarsana News

With 5.4% CAGR, Allergic Conjunctivitis Market Size worth

According to Fortune Business Insights, The Allergic Conjunctivitis Market size is anticipated to reach USD 3.60 Billion by 2028, the market size was USD...

Daiso Singapore recalls H&H Tiramisu Twist cookies due to presence of undeclared allergens - Vimarsana News

Daiso Singapore recalls H&H Tiramisu Twist cookies due to presence of undeclared allergens

The Singapore Food Agency (SFA) has directed Daiso Singapore to recall H&H Tiramisu Twist cookies due to the presence of undeclared allergens. Read more at stomp.straitstimes.com

One Way to Kill Fire Ants Instantly: Eat Them - Vimarsana News

One Way to Kill Fire Ants Instantly: Eat Them

Research suggests lizards gain immunity against fire ant venom by eating them, which could also be possible for humans.

Orexo announces positive data from phase 1 clinical study for OX640 - a nasal epinephrine rescue medication for allergic reactions - Vimarsana News

Orexo announces positive data from phase 1 clinical study for OX640 - a nasal epinephrine rescue medication for allergic reactions

All four investigational formulations of OX640 were extensively absorbed and rapidly achieved clinically relevant plasma levels of epinephrine Data available today indicates significantly improved